News
IBD: Inpatient opioids linked with outpatient use
January 26, 2020
Alternative analgesics should be considered for patients with inflammatory bowel disease.
News
Geriatric IBD hospitalization carries steep inpatient mortality
November 21, 2019
SAN ANTONIO – A major unmet need exists for better guideline-directed management of geriatric patients hospitalized for IBD.
News
A sepsis death linked to fecal microbiota transplantation
October 30, 2019
Two patients developed bacteremia after receiving a fecal microbiota transplant from the same donor whose stool contained extended-spectrum beta-lactamase-producing E. coli.
News
Older IBD patients are most at risk of postdischarge VTE
September 10, 2019
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
News
Beyond C. difficile: The future of fecal microbial transplantation
July 29, 2019
SAN DIEGO – Future directions for microbial transplantation range from multifactorial and functional gut disorders to consideration of the small intestinal microbiome.
News
Fewer antibiotics prescribed with PCR than conventional stool testing
June 11, 2019
SAN DIEGO – Endoscopy, abdominal imaging also less common with polymerase chain reaction–based testing.
News
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing.
News
More fiber looks safe, might benefit ICU patients
March 27, 2019
MIAMI – Each 10-g increase in fiber intake over 72 hours correlated with a 0.3% median increase in the relative abundance of short-chain fatty acid–producing bacteria (P less than .01).
News
NIH announces new clinical trial assessing FMT for recurrent CDAD
January 15, 2019
The trial will test the safety and efficacy of a standardized protocol with follow-up.
News
Anaerobically prepared donor FMT led to steroid-free remission of ulcerative colitis
January 15, 2019
Eight weeks after FMT, 32% of the donor group achieved steroid-free remission, compared with 9% of the autologous FMT group (odds ratio, 5; P = .03).